4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-020386
Chief Product Strategy Officer sold 2,283 shares at $8.06 ($18,401)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-020386
Chief Product Strategy Officer sold 2,283 shares at $8.06 ($18,401)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…